William Loging Press Release

FOR IMMEDIATE RELEASE

Dr. William T. Loging Launches Bioinformatics and Computational

Biology in Drug Discovery and Development

With Signing and Discussion held on Wednesday, June 1st at The New York Academy of Sciences On Wednesday, June 1st , from 4:00pm to 8:00pm, The New York Academy of Sciences (7 World Trade Center, 250 Greenwich Street, 40th Floor) will host a book signing and discussion with Dr. William T. Loging.

Dr. Loging will be discussing his new book Bioinformatics and Computational Biology in Drug Discovery and Development (published by Cambridge University Press, $74.99) alongside contributor Dr. Eric Schadt, and guest Dr. Richie Etwaru.

From the book, “…we see now rising a new generation of biologists who are being trained simultaneously in traditional biomedical sciences, as well as in informatics and statistics. It is these new biologists that will help drive revolutionary progress in the biomedical sciences and in healthcare. I sincerely hope that the approaches and technologies described in this book will inspire this next generation of scientists on how to engage this emerging consumer-centric model of healthcare, to think and dream big about the future of healthcare and drug discovery, and in so doing positively impact the human race by enhancing our well-being.”

William T. Loging has spent the past 20 years focused on generating

treatments for human disease. Bridging both clinical genomics and pharmaceutical sciences, he has been globally recognized for his work with Maraviroc (Selzentry™) for use in HIV. The results of his past contribution to the approval of Empagliflozin (Jardiance™) were listed within the drug insert. He has published in several leading scientific journals on utilization of novel informatics approaches to Drug Discovery and his 2014 TEDx talk on Cancer Genomics was highly acclaimed. He currently holds several appointments at the Mt Sinai School of Medicine where he focuses on the clinical fields of Oncology and Immunology of which he holds several patents.

“Bioinformatics and Computational Biology in Drug Discovery and Development is a road map to an inevitable future - a future where data define disease, diagnosis and drugs. This book is an essential

companion for anyone in drug development who has one foot in the present and one in the future." John Nosta, Google Health Board Member Dr. Eric Schadt is Genomics Department Chair at Mt Sinai School of Medicine and an expert on the

generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. He is known for calling for a shift in molecular biology toward a network-oriented view of living systems to complement the reductionist, single-gene approaches that currently dominate biology in order to more accurately model the complexity of biological systems.

Dr. Richie Etwaru is helping bridge the innovation and efficiency gap for healthcare stakeholders and life

sciences customers using analytics and technology. He joined IMS Health as part of the Cegedim acquisition where he served in the same chief digital officer capacity. Before that, Dr. Etwaru worked for UBS Wealth Management and Barclays where he focused on innovation and technology. Dr. Etwaru is also a serial entrepreneur who has started several companies, as well as an author and regular contributor to Forbes.com and Huffington Post.

Press and others may RSVP to the event at: http://www.biopharmaresearchcouncil.org/loging-book-signing For an author interview or more information please contact Diana Rissetto, Senior Media Associate at Cambridge University Press: drissetto@cambridge.org

About Cambridge University Press

Cambridge University Press dates from 1534 and is part of the University of Cambridge. We further the University's mission by disseminating knowledge in the pursuit of education, learning and research at the highest international levels of excellence. Playing a leading role in today's global marketplace, we have over 50 offices around the globe, and we distribute our products to nearly every country in the world. We publish titles written by authors in over 100 different countries.

For further information, please visit: www.cambridge.org